🧫

Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts

active
experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-als-spor
🧫 Experiment Protocol Clinicalproposed
SUMMARY
# Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts ## Background and Rationale Sporadic amyotrophic lateral sclerosis (ALS) accounts for approximately 90% of cases, yet the biological triggers initiating motor neuron degeneration in genetically predisposed individuals remain poorly understood. This longitudinal clinical study employs comprehensive deep phenotyping of at-risk cohorts to identify the earliest molecular and cellular events preceding clinical symptom onset. The e
METHODOLOGY NOTES
# Sporadic ALS Initiation Biology: Deep Phenotyping Protocol ## Phase 1: Cohort Recruitment and Baseline Characterization (Months 1-12) **Participant Selection and Stratification**: Recruit 500 at-risk individuals (age 40-75) meeting criteria: (1) first-degree relatives of sALS patients (n=200), (2) occupational/environmental exposure history (n=150), (3) subclinical neurophysiological abnormalities on screening electromyography (n=100), (4) elevated serum phosphorylated tau or neurofilament light chain (>75th percentile; n=50). Enroll 300 age-matched, exposure-matched controls. Perform comprehensive clinical assessments including ALS Functional Rating Scale-Revised (ALSFRS-R), Medical Research Council grading, quantitative grip strength dynamometry, and detailed occupational/environmental exposure questionnaires. ## Phase 2: Multi-Modal Deep Phenotyping (Months 3-24) **Neuroimaging Protocol**: Conduct 3T MRI brain and spinal cord imaging with quantitative T2 relaxometry, diffusion t
Metadatasource: {'type': 'manual', 'source_name': 'wiki'
source{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.897417Z'}
summary# Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts ## Background and Rationale Sporadic amyotrophic lateral sclerosis (ALS) accounts for approximately 90% of cases, yet the biologi
entities{'genes': ['CASP1/CGAS/CRH'], 'diseases': ['ALS']}
model_systemhuman
_schema_version1
experiment_typeclinical
primary_outcomeIdentification of molecular signature predictive of ALS development within 2-3 years, combining genetic risk scores, biofluid biomarkers, and neurophysiological changes with >80% predictive accuracy.
methodology_notes# Sporadic ALS Initiation Biology: Deep Phenotyping Protocol ## Phase 1: Cohort Recruitment and Baseline Characterization (Months 1-12) **Participant Selection and Stratification**: Recruit 500 at-ri
replication_statussingle_study
extraction_metadata{'backfill_at': '2026-04-16T01:00:16.897423', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}
📊 Evidence Profile Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
556
Outgoing
484
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.